Terms: = Pancreatic cancer AND BCL11A, BCL11A-L, 53335, ENSG00000119866, FLJ34997, CTIP1, BCL11A-S, BCL11A-XL, KIAA1809, Q9H165, EVI9, FLJ10173
5 results:
1. Development of a Transcription Factor-Based Prognostic Model for Predicting the Immune Status and Outcome in pancreatic Adenocarcinoma.
Zhang X; Li L; Liu P; Tian Y; Gong P
J Immunol Res; 2022; 2022():4946020. PubMed ID: 35571561
[TBL] [Abstract] [Full Text] [Related]
2. Identification of new candidate genes and signalling pathways associated with the development of neuroendocrine pancreatic tumours based on next generation sequencing data.
Kit OI; Trifanov VS; Petrusenko NA; Gvaldin DY; Kutilin DS; Timoshkina NN
Mol Biol Rep; 2020 Jun; 47(6):4233-4243. PubMed ID: 32451928
[TBL] [Abstract] [Full Text] [Related]
3. Exploring specific prognostic biomarkers in triple-negative breast cancer.
Bao C; Lu Y; Chen J; Chen D; Lou W; Ding B; Xu L; Fan W
Cell Death Dis; 2019 Oct; 10(11):807. PubMed ID: 31649243
[TBL] [Abstract] [Full Text] [Related]
4. Genetic regulation of fetal haemoglobin in inherited bone marrow failure syndromes.
Alter BP; Rosenberg PS; Day T; Menzel S; Giri N; Savage SA; Thein SL
Br J Haematol; 2013 Aug; 162(4):542-6. PubMed ID: 23713742
[TBL] [Abstract] [Full Text] [Related]
5. Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data.
Pierce BL; Austin MA; Ahsan H
Cancer Causes Control; 2011 Jun; 22(6):877-83. PubMed ID: 21445555
[TBL] [Abstract] [Full Text] [Related]
